Pharmacy Board of Australia - Search
Look up a health practitioner

Close

Check if your health practitioner is qualified, registered and their current registration status
16 search results for
  • June 2016

    Pharmacy Board
    Methotrexate incidents. Following recent publication of research in the Medical Journal of Australia about methotrexate-related adverse events, the Board reiterates its…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/June-2016.aspx
  • Methotrexate and patient harm: an analysis of notifications involving oral methotrexate in Australia 2010 to 2019

    Australian Health Practitioner Regulation Agency
    Data was coded to identify. Key Messages. • Methotrexate is a high-risk medicine. • ... Oral cytotoxic medicines, including methotrexate, must be packed separately to a…
    Date published 22 March 2021
    Download document
    pdf document
    PDF
    199.2KB
    View as HTML
  • Tribunal reprimands pharmacist for unsafe dispensing

    Australian Health Practitioner Regulation Agency
    In January 2015, pharmacist Jennifer Barca dispensed an unsafe dose of methotrexate to a patient who subsequently died from complications of methotrexate toxicity. ... A…
    Date published 1 January 2001
    www.ahpra.gov.au/News/2021-01-22-Tribunal-reprimands-pharmacist.aspx
  • Research, strategy and policy

    Australian Health Practitioner Regulation Agency
    a review of notifications about pharmacists involving the dispensing of oral methotrexate.
    Date published 1 January 2011
    www.ahpra.gov.au/Publications/Annual-reports/Annual-Report-2020/Research-strategy.aspx
  • March 2021

    Pharmacy Board
    Methotrexate is an anti-inflammatory drug. It is also a cytotoxic used in cancer chemotherapy. ... The patient’s general practitioner prescribed methotrexate to treat a…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/March-2021.aspx
  • October 2014

    Pharmacy Board
    The prescription for methotrexate was correctly dispensed by a pharmacist for packaging into a DAA for use by the patient. ... The setting out of the patient’s medication…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/October-2014.aspx
  • Guidelines for dispensing of medicines - 7 May 2018

    Pharmacy Board
    alendronate, methotrexate) • when a new medicine is prescribed • when there is a change in the dose or frequency of administration • when the brand of medicine has changed •…
    Date published 10 March 2023
    Download document
    pdf document
    PDF
    200.5KB
    View as HTML
  • Professional Practice Issues

    Pharmacy Board
    Methotrexate and patient harm - an analysis of notifications involving oral methotrexate in Australia 2010 to 2019 (195 KB,PDF).
    Date published 1 January 2004
    www.pharmacyboard.gov.au/News/Professional-Practice-Issues.aspx
  • Meeting of the Pharmacy Board of Australia - 23 May 2014

    Pharmacy Board
    The prescription for methotrexate was correctly dispensed by a pharmacist for packaging into a dose administration aid (DAA) for use by the patient. ... The setting out of…
    Date published 13 June 2014
    Download document
    pdf document
    PDF
    273.7KB
    View as HTML
  • October 2015

    Pharmacy Board
    In this particular case, a pregnant woman was responsible for administration of the dispensed medicine (methotrexate) to the patient, but was not advised about the necessary…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/October-2015.aspx
Displaying results 1 to 10 of 16
 
Page reviewed 28/07/2015